Form 4: Agenus Inc. Director Jennifer Buell Acquires Shares as Part of Salary Compensation

Director Jennifer Buell acquired 545 shares of Agenus Inc. common stock as part of her salary compensation, according to a recent SEC filing.

Summary

• On February 21, 2025, Jennifer Buell, a director of Agenus Inc., acquired 545 shares of the company's common stock.
• The acquisition was part of her salary compensation, with the shares being issued in lieu of cash.
• The price per share was $3.32, which was the closing price of Agenus Inc. common stock on that date.
• Following the transaction, Buell directly owns 15,237 shares.
• The shares were issued under the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan and are fully vested upon issuance.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction, indicating a stable and ongoing compensation strategy. The sentiment is neutral to slightly positive as it shows alignment of interests between the director and shareholders.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.
• The use of stock as part of compensation aligns the director's interests with those of the shareholders.

Management Comments

• At her request and with the approval of the Agenus Inc. Compensation Committee, a portion of Jennifer Buell's salary is being paid in stock, in lieu of cash.

Industry Context

Directors receiving stock as part of their compensation is a common practice in the biotech industry to align their interests with shareholders and incentivize long-term growth.

Comparison to Industry Standards

• Many biotech companies use equity compensation plans to attract and retain talent, similar to Agenus Inc.'s approach.
• Comparing Agenus Inc.'s equity compensation plan to those of companies like Gilead Sciences or Amgen would provide a broader context.

Stakeholder Impact

• Shareholders may view the director's stock acquisition positively, as it aligns her interests with the company's performance.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates